Relevant bibliographies by topics / Parkinson's disease; Neuroscience

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Parkinson's disease; Neuroscience'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Parkinson's disease; Neuroscience.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Parkinson's disease; Neuroscience"

1

Dauer, William, and Serge Przedborski. "Parkinson's Disease." Neuron 39, no. 6 (2003): 889–909. http://dx.doi.org/10.1016/s0896-6273(03)00568-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Allain, Hervé, Danièle Bentué-Ferrer, and Yvette Akwa. "Disease-modifying drugs and Parkinson's disease." Progress in Neurobiology 84, no. 1 (2008): 25–39. http://dx.doi.org/10.1016/j.pneurobio.2007.10.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wider, Christian, Sarah J. Lincoln, Michael G. Heckman, et al. "Phactr2 and Parkinson's disease." Neuroscience Letters 453, no. 1 (2009): 9–11. http://dx.doi.org/10.1016/j.neulet.2009.02.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Agid, Y., and F. Javoy-Agid. "Peptides and Parkinson's disease." Trends in Neurosciences 8 (January 1985): 30–35. http://dx.doi.org/10.1016/0166-2236(85)90012-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

William Langston, J. "MPTP and parkinson's disease." Trends in Neurosciences 8 (January 1985): 79–83. http://dx.doi.org/10.1016/0166-2236(85)90031-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Robbins, Trevor W., and Roshan Cools. "Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective." Movement Disorders 29, no. 5 (2014): 597–607. http://dx.doi.org/10.1002/mds.25853.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dekker, M. "Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism." Neuroscience Letters 348, no. 2 (2003): 117–19. http://dx.doi.org/10.1016/s0304-3940(03)00713-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Venhovens, J., J. Meulstee, B. R. Bloem, and W. I. M. Verhagen. "Neurovestibular analysis and falls in Parkinson's disease and atypical parkinsonism." European Journal of Neuroscience 43, no. 12 (2016): 1636–46. http://dx.doi.org/10.1111/ejn.13253.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vanhauwaert, Roeland, and Patrik Verstreken. "Flies with Parkinson's disease." Experimental Neurology 274 (December 2015): 42–51. http://dx.doi.org/10.1016/j.expneurol.2015.02.020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Okai, David. "Neuropsychiatric sequelae of Parkinson's disease: what every clinician needs to know." BJPsych Advances 26, no. 6 (2020): 343–45. http://dx.doi.org/10.1192/bja.2020.70.

Full text
Abstract:
SUMMARYJones et al's review of the assessment and management of the neuropsychiatric manifestations of Parkinson's disease serves as a practical guide to clinicians. This commentary outlines some of the underlying neuroscience and psychological sequelae of this range of conditions, offering a takeaway message to the clinician with an interest in Parkinson's neuropsychiatry.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Parkinson's disease; Neuroscience"

1

Ikuta, Toshikazu. "fMRI study of grammar, Parkinson's disease and dopaminergic medication." [Bloomington, Ind.] : Indiana University, 2008. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3337540.

Full text
Abstract:
Thesis (Ph.D.)--Indiana University, Program of Neuroscience and the Dept. of Linguistics, 2008.<br>Title from PDF t.p. (viewed on Jul 27, 2009). Source: Dissertation Abstracts International, Volume: 69-11, Section: B, page: 6602. Adviser: Laura L. Murray.
APA, Harvard, Vancouver, ISO, and other styles
2

Crocker, Stephen J. "Novel therapeutic strategies for the treatment of Parkinson's disease." Thesis, University of Ottawa (Canada), 2001. http://hdl.handle.net/10393/9053.

Full text
Abstract:
Parkinson's disease (PD) is a common neurodegenerative disorder associated with the loss of dopamine neurons located in the substantia nigra pars compacta. Current pharmacological approaches for the treatment of PD are confounded by development of abnormal involuntary movements called dyskinesias, and offer limited long-term utility because they do not stop the disease progression. Accordingly, this thesis addressed two primary issues limiting the present treatments of Parkinson's disease: the molecular basis of dopamine receptor-related dyskinesias, and attenuation of dopamine neuron death. A
APA, Harvard, Vancouver, ISO, and other styles
3

Biswas, Amitava. "Perioral sensorimotor integration in Parkinson's disease." [Bloomington, Ind.] : Indiana University, 2005. http://wwwlib.umi.com/dissertations/fullcit/3183913.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Alexopoulou, Zoi. "The study of the deubiquitinase USP8 in Parkinson's disease pathogenesis." Thesis, University of Oxford, 2016. https://ora.ox.ac.uk/objects/uuid:47c2941b-5232-4bd0-92fa-e59aac16af7c.

Full text
Abstract:
Parkinson's disease is the second commonest neurodegenerative disease currently treated symptomatically. It is a multifactorial disease involving mechanisms ranging from protein aggregation to mitochondrial dysfunction, oxidative stress and dopamine dysregulation. The levels of &alpha;-synuclein have been causatively linked to the development and progression of Parkinson's disease. Therefore &alpha;-synuclein lowering strategies are valid approaches in Parkinson's disease. Neuropathologically, Lewy Bodies in the vulnerable substantia nigra of Parkinson's disease patients are less ubiquitinated
APA, Harvard, Vancouver, ISO, and other styles
5

Little, Simon. "Adaptive deep brain stimulation for Parkinson's disease : closed loop stimulation for Parkinson's." Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:5b76616a-7d5e-424e-9c66-5d48b19cae1c.

Full text
Abstract:
Our understanding of the pathophysiology Parkinson’s disease has transformed over the last decade as we have come to appreciate the importance of changes in neuronal firing pattern that occur within the motor network in the dopamine deficient state. These changes in firing pattern, particularly increased synchrony result in oscillations that can be recorded as local field potentials. This thesis concerns itself with the study of beta oscillations which are characteristic of Parkinson’s disease. Firstly, I investigate whether beta oscillations play a pathophysiological role in Parkinson’s disea
APA, Harvard, Vancouver, ISO, and other styles
6

Marshall, Victoria Louise. "Clinical and functional imaging correlates in Parkinson's disease." Thesis, University of Glasgow, 2006. http://theses.gla.ac.uk/7012/.

Full text
Abstract:
Parkinson's disease (PD) is misdiagnosed throughout its disease course for conditions such as essential tremor, drug-induced parkinsonism, vascular pseudo-parkinsonism, Alzheimer's disease and other degenerative parkinsonian diseases. This thesis aims to verify the accuracy of dopaminergic imaging in early and uncertain parkinsonian/tremor disorders through 3 studies. The first is a prospective United Kingdom multicentre assessment of [1231] FP-CIT SPECT use in 190 patients in pre-defined diagnostic categories and with particular focus on clinical features to assess the influence of imaging in
APA, Harvard, Vancouver, ISO, and other styles
7

Kabbach, Ghassan. "Interactions of LRRK2 in a Drosophila melanogaster model of Parkinson's disease." Thesis, University of Ottawa (Canada), 2010. http://hdl.handle.net/10393/28820.

Full text
Abstract:
Parkinson's disease is the most common movement disorder. A complex neurodegenerative disease, its cause and progressive nature are of unknown roots, making a final cure currently unattainable. Recently, mutations in LRRK2 have been deemed the most common cause of both familial and sporadic forms of Parkinson's disease. Itself a mysterious protein, it harbors pathogenic mutations in all of its complex functional domains. Here, we present a Drosophila melanogaster model of LRRK2 by creating four different human LRRK2 transgenic flies. Wild type LRRK2, and LRRK2 mutants I1122V, Y1699C, and I202
APA, Harvard, Vancouver, ISO, and other styles
8

Acosta, Glen Howel G. "Susceptibility of parkinson's disease following mild blast traumatic brain injury." Thesis, Purdue University, 2015. http://pqdtopen.proquest.com/#viewpdf?dispub=1571943.

Full text
Abstract:
<p> Blast injury-induced neurotrauma (BINT) is steadily increasing in prevalence due to escalated terror activity and constitutes the signature injury associated with current military conflicts. BINT produces significant neurological deficiencies and there is a growing concern that the injury may produce long-term consequences that affect the resilience and the performance of soldiers. One of the potential consequences is an increased susceptibility to Parkinson's disease (PD). A vital goal aimed at curtailing the post-deployment long-term consequences of blast injury-induced neurotrauma is to
APA, Harvard, Vancouver, ISO, and other styles
9

Song, Linyang 1978. "The role of astroglial HO-1 in the pathogenesis of Parkinson's disease /." Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=98803.

Full text
Abstract:
The mechanisms responsible for the progressive loss of dopaminergic neurons and pathological iron deposition in the substania nigra pars compacta of patients with Parkinson disease (PD) remain incompletely understood. Heme oxygenase-1 (HO-1), the rate-limiting enzyme in the degradation of heme to biliverdin, carbon monoxide, and ferrous iron, is up-regulated in affected PD astroglia and may contribute to aberrant mitochondrial iron sequestration in these cells. To determine whether glial HO-1 hyperexpression is inimical to nearby neuronal constituents, we co-cultured dopaminergic PC12 cells at
APA, Harvard, Vancouver, ISO, and other styles
10

Malek, Naveed. "Variation in Parkinson's disease : age, gender, genotype and phenotype correlations in early onset disease." Thesis, University of Glasgow, 2014. http://theses.gla.ac.uk/5602/.

Full text
Abstract:
There is a wide variation in the phenotypic expression, progression rates, therapy response and complications in Parkinson’s disease (PD). The primary research objective in this thesis was to analyse the variation in the 4 domains of phenotypic expression i.e. motor, non-motor, cognitive, and quality of life in a subset of early onset Parkinson’s disease (EOPD) patients from the PRoBaND study, in the United Kingdom. The secondary objective was to explore the factors responsible for this variation or heterogeneity in the clinical characteristics. Linking genotypes with phenotypes, besides evalu
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Parkinson's disease; Neuroscience"

1

Recent advances in Parkinson's disease. Elsevier, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pieter, Voorn, Berendse Henk W, Mulder Antonius B, Cools Alexander Rudolf 1941-, and SpringerLink (Online service), eds. The Basal Ganglia IX. Springer-Verlag New York, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hirosaki International Forum of Medical Science (6th 2002 Hirosaki-shi, Japan). Advances in brain research: Cerebrovascular disorders and neurodegeneration : proceedings of the 6th Hirosaki International Forum of Medical Science, held in Hirosaki, Japan, between 15 and 16 October 2002. Edited by Satoh Kei, Suzuki Shigeharu M. D, and Matsunaga Muneo. Elsevier, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Neuroscience of Parkinson's Disease. Elsevier Science & Technology, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Preedy, Victor R., and Colin R. Martin. Neuroscience of Parkinson's Disease. Elsevier Science & Technology Books, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tolosa, Eduardo, and Joseph J. Jankovic. Parkinson's Disease & Movement Disorders. 4th ed. Lippincott Williams & Wilkins, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Joseph, Jankovic, and Tolosa Eduardo, eds. Parkinson's disease and movement disorders. 4th ed. Lippincott Williams & Wilkins, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

(Editor), C. W. Olanow, Peter Jenner (Editor), and Moussa Youdim (Editor), eds. Neurodegeneration and Neuroprotection in Parkinson's Disease (Neuroscience Perspectives). Academic Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Preedy, Victor R., and Colin R. Martin. Diagnosis and Management in Parkinson's Disease: The Neuroscience of Parkinson's, Volume 1. Elsevier Science & Technology Books, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Preedy, Victor R., and Colin R. Martin. Diagnosis and Management in Parkinson's Disease: The Neuroscience of Parkinson's, Volume 1. Elsevier Science & Technology, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Parkinson's disease; Neuroscience"

1

Elkis-Abuhoff, Deborah, and Morgan Gaydos. "Medical Art Therapy Applied to the Trauma Experienced by those Diagnosed with Parkinson's Disease." In Art Therapy, Trauma, and Neuroscience. Routledge, 2021. http://dx.doi.org/10.4324/9781003196242-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Double, Kay, and John Finberg. "Parkinson’s Disease." In Neuroscience in the 21st Century. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-1997-6_112.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Double, Kay, and John Finberg. "Parkinson’s Disease." In Neuroscience in the 21st Century. Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3474-4_112.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bratt-Leal, Andrés M., and Jeanne F. Loring. "Stem Cells for Parkinson’s Disease." In Translational Neuroscience. Springer US, 2016. http://dx.doi.org/10.1007/978-1-4899-7654-3_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ceballos-Picot, Irène. "Oxidative Stress in Parkinson’s Disease." In Neuroscience Intelligence Unit. Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-662-22516-5_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kaplitt, Michael G., and Matthew J. During. "GAD Gene Therapy for Parkinson’s Disease." In Translational Neuroscience. Springer US, 2016. http://dx.doi.org/10.1007/978-1-4899-7654-3_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Beuter, Anne. "Parkinson’s Disease: Deep Brain Stimulation." In Encyclopedia of Computational Neuroscience. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-6675-8_510.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Müller, F., and G. E. Stelmach. "Scaling Problems in Parkinson’s Disease." In Tutorials in Motor Neuroscience. Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3626-6_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Beuter, Anne. "Parkinson’s Disease: Deep Brain Stimulation." In Encyclopedia of Computational Neuroscience. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-7320-6_510-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lavano, Angelo, and Anne Beuter. "Parkinson’s Disease: Deep Brain Stimulation." In Encyclopedia of Computational Neuroscience. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4614-7320-6_510-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Parkinson's disease; Neuroscience"

1

Chong, Raymond, Chandramohan Wakade, and Eric Bradley. "Plasma Cytokines and Sleep Quality in Parkinson's Disease." In Annual International Conference on Neuroscience and Neurobiology Research. Global Science & Technology Forum (GSTF), 2014. http://dx.doi.org/10.5176/2345-7813_cnn14.09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Alessenko, Alice, Viktor Blokhin, Sergei Sokolov, et al. "ROLE OF SPHINGOLIPIDS IN THE PATHOGENESIS OF PARKINSON'S DISEASE." In XVI International interdisciplinary congress "Neuroscience for Medicine and Psychology". LLC MAKS Press, 2020. http://dx.doi.org/10.29003/m909.sudak.ns2020-16/59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chigaleychik, Larisa, Elena Teslenko, and Vsevolod Poleschuk. "STABILOMETRIC INDICATORS IN THE EARLY STAGES OF PARKINSON'S DISEASE." In XVII INTERNATIONAL INTERDISCIPLINARY CONGRESS NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY. LCC MAKS Press, 2021. http://dx.doi.org/10.29003/m2401.sudak.ns2021-17/423-424.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Grachova, Elizaveta, Anastsia Kudrevatykh, Irina Miliukhina, Tatiana Novikova, Timofey Sergeev, and Nikolay Suvorov. "AUTONOMIC DISORDERS IN PARKINSON'S DISEASE AND METHODS OF THEIR CORRECTION." In XVI International interdisciplinary congress "Neuroscience for Medicine and Psychology". LLC MAKS Press, 2020. http://dx.doi.org/10.29003/m1005.sudak.ns2020-16/161.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rajendran, Arathi, Anuja Thankamani, Nishamol Nirmala, Bipin Nair, and Shyam Diwakar. "Computational neuroscience of substantia nigra circuit and dopamine modulation during parkinson's disease." In 2017 International Conference on Advances in Computing, Communications and Informatics (ICACCI). IEEE, 2017. http://dx.doi.org/10.1109/icacci.2017.8125892.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Khidiyatova, Irina, Gulnara Akhmadeeva, Irina Gilyazova, et al. "THE ROLE OF MONOAMINE METABOLISM SYSTEM GENES IN NEUROPSYCHOLOGICAL MANIFESTATIONS OF PARKINSON'S DISEASE." In XVI International interdisciplinary congress "Neuroscience for Medicine and Psychology". LLC MAKS Press, 2020. http://dx.doi.org/10.29003/m1317.sudak.ns2020-16/494-495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Danilova, Nina, and Elena Strabykina. "IN THE PATIENTS WITH PARKINSON'S DISEASE REVEALED INCREASED ALPHA RHYTHM, WHICH EXCEEDS THE NORM." In XV International interdisciplinary congress "Neuroscience for Medicine and Psychology". LLC MAKS Press, 2019. http://dx.doi.org/10.29003/m376.sudak.ns2019-15/158-159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ryabchikova, Nataliya, Elena Damjanovic, Larisa Chigaleychik, and Boris Baziyan. "SACCAD EYES MOVEMENTS UNDER PROGNOSTIC ACTIVITY IN PATIENTS WITH EARLY STAGES OF PARKINSON'S DISEASE." In XV International interdisciplinary congress "Neuroscience for Medicine and Psychology". LLC MAKS Press, 2019. http://dx.doi.org/10.29003/m538.sudak.ns2019-15/356-358.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bazyan, Ara. "COMMON PROCESSES OF DEVELOPMENT OF VARIOUS PATHOLOGIES: DRUG ADDICTION, ABSENCE EPILEPSY, PARKINSON'S DISEASE, RADIATION DISORDERS." In XIV International interdisciplinary congress "Neuroscience for Medicine and Psychology". LLC MAKS Press, 2018. http://dx.doi.org/10.29003/m174.sudak.ns2018-14/88.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bondarchuk, Vladimir. "COMPLEX METHOD OF NEUROLOGY, REFLEXOLOGY AND MANUAL THERAPY IN REHABILITATION OF PATIENTS WITH PARKINSON'S DISEASE." In XVII INTERNATIONAL INTERDISCIPLINARY CONGRESS NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY. LCC MAKS Press, 2021. http://dx.doi.org/10.29003/m2063.sudak.ns2021-17/86-87.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Parkinson's disease; Neuroscience' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography